Patent EP2,689,806 A1 by Harsh and Gittins (2014); Title: Oral compositions containing extracts of Myristica fragrans and related methods. The patent describes compositions comprising a combination of extracts
(2020) reported molecular docking studies of 100 major phytocompounds of ten selected medicinal plants (Rheum emodi, Thymus serpyllum, Cymbopogon citratus, Moringa oleifera, Thalictrum foliolosum, Berberis aristata, Piper nigrum, Allium sativum, Myristica fragrans and Zanthoxylum armatum) for interaction...
fragrans 3.1. Myristicin The organic compound myristicin, which is abundant in plants, such as nutmeg and parsley, has recently been identified as a strong antibacterial agent. Its antimicrobial efficacy is associated with its impact on bacterial membranes. Myristicin is hydrophobic and has an ...
Potentially useful in the treatment of neurodegenerative disorders, Kaempferia parviflora and Myristica fragrans have been shown to possess a wide spectrum of neuropharmacological activities and neuroprotective effects in vivo and in vitro. In this study, we determined whether and how K. parviflora ethano...